E-LIB Suche - Ergebnisse für: Van Rij, Catharina M.

1

Pretargeted ImmunoPET of Prostate Cancer with an Anti-TROP-..:

van Rij, Catharina M. ; Frielink, Cathelijne ; Goldenberg, David M....
Molecular Imaging and Biology. 17 (2014) 1 - p. 94-101 , 2014

Link: https://doi.org/10.1007/..

2

Pretargeted immuno-PET and radioimmunotherapy of prostate c..:

van Rij, Catharina M. ; Lütje, Susanne ; Frielink, Cathelijne...
European Journal of Nuclear Medicine and Molecular Imaging. 40 (2013) 9 - p. 1377-1383 , 2013

Link: https://doi.org/10.1007/..

3

Prospects in radionuclide imaging of prostate cancer:

Lütje, Susanne ; Boerman, Otto C. ; van Rij, Catharina M....
The Prostate. 72 (2011) 11 - p. 1262-1272 , 2011

Link: https://doi.org/10.1002/..

4

Population plasma pharmacokinetics of 11C‐flumazenil at tra..:

Van Rij, Catharina M. ; Huitema, Alwin D. R. ; Swart, Eleonora L....
British Journal of Clinical Pharmacology. 60 (2005) 5 - p. 477-485 , 2005

Link: https://doi.org/10.1111/..

5

Stability of 10B-l-boronophenylalanine–fructose injection:

van Rij, Catharina M. ; Sinjewel, Arno ; van Loenen, Arie C....
American Journal of Health-System Pharmacy. 62 (2005) 24 - p. 2608-2610 , 2005

Link: https://doi.org/10.2146/..

6

Targeting human prostate cancer with In-111-labeled D2B IgG..:

Lutje, Susanne ; van Rij, Catharina M ; Franssen, Gerben M...
https://research.rug.nl/en/publications/1cccd119-ff5c-431d-bc23-0d68ec0ce740. , 2014

Link: https://hdl.handle.net/1..

7

Pretargeted Radioimmunotherapy of Prostate Cancer with an A..:

van Rij, Catharina M ; Frielink, Cathelijne ; Goldenberg, David M...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4186637/. , 2014

Link: http://www.ncbi.nlm.nih...

8

Population plasma pharmacokinetics of 11C-flumazenil at tra..:

van Rij, Catharina M ; Huitema, Alwin D R ; Swart, Eleonora L...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1884950. , 2005

Link: http://www.ncbi.nlm.nih...

9

Noninvasive Prenatal Test Results Indicative of Maternal Ma..:

Heesterbeek, Catharina J ; Aukema, Sietse M ; Galjaard, Robert-Jan H...
https://research.rug.nl/en/publications/b9858dcd-c6ac-42ea-80ee-5ac7418f4648. , 2022

Link: https://hdl.handle.net/1..

10

Evaluation of Circulating Tumor DNA as a Liquid Biomarker i..:

de Bruyn, Daniel P. ; van Poppelen, Natasha M. ; Brands, Tom...
Investigative Opthalmology & Visual Science. 65 (2024) 2 - p. 11 , 2024

Link: https://doi.org/10.1167/..

11

Time Trends in the Treatment and Survival of 5036 Uveal Mel..:

Tong, Thaïs M. L. ; Bastiaannet, Esther ; Speetjens, Frank M....
Cancers. 15 (2023) 22 - p. 5419 , 2023

Link: https://doi.org/10.3390/..

12

SAFESTEREO: phase II randomized trial to compare stereotact..:

Crouzen, J. A. ; Petoukhova, A. L. ; Broekman, M. L. D....
BMC Cancer. 23 (2023) 1 - p. , 2023

Link: https://doi.org/10.1186/..

13

Physiological relationship between cardiorespiratory fitnes..:

Roxburgh, Brendon H. ; Cotter, James D. ; Campbell, Holly A....
British Journal of Anaesthesia. 130 (2023) 2 - p. 122-132 , 2023

Link: https://doi.org/10.1016/..

14

Exercise, Bulging Veins and Venous Disease:

van Rij, André M. ; Thomas, Kate N.
European Journal of Vascular and Endovascular Surgery. 66 (2023) 6 - p. 864-865 , 2023

Link: https://doi.org/10.1016/..

15

JS01.4.A CENTRALIZED CRANIOSPINAL PROTON THERAPY FOR MEDULL..:

van den Berg, L L ; Maduro, J H ; Bannink-Gawryszuk, A...
Neuro-Oncology. 25 (2023) Supplement_2 - p. ii6-ii7 , 2023

Link: https://doi.org/10.1093/..